When Fat Drives Sleep Apnea: Scientists Push to Define Adiposity-Attributable Disease
A new letter in the Journal of Clinical Sleep Medicine argues that obesity-driven obstructive sleep apnea should be formally defined ...
A new letter in the Journal of Clinical Sleep Medicine argues that obesity-driven obstructive sleep apnea should be formally defined ...
A network meta-analysis of four randomized trials in 14,348 adults with type 2 diabetes finds that higher doses of tirzepatide ...
A post hoc analysis of the SURMOUNT-OSA trials shows that losing at least 10 percent of body weight within the ...
Post hoc analyses of the SURMOUNT-OSA trials show tirzepatide improved sleep apnea severity, weight, and blood pressure across all baseline ...
A meta-analysis of 19 high-potency incretin trials finds that objective signs of malnutrition and lean mass loss occur far more ...
A comparative narrative review finds tirzepatide delivers the largest HbA1c and weight reductions among incretin therapies, while semaglutide leads on ...
Exit interviews with 74 long-term participants in the SURPASS-CVOT trial reveal that tirzepatide and dulaglutide produced perceived benefits in glycemic ...
A Bayesian re-analysis of six clinical trials estimates that people who stop semaglutide or tirzepatide regain roughly one kilogram per ...
The ongoing T-BEAT observational study is evaluating real-world glycemic and weight outcomes of tirzepatide versus oral semaglutide in Japanese adults ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine